Mechanisms of aortic valve calcification

被引:192
作者
Mohler, ER [1 ]
机构
[1] Univ Penn, Sch Med, Dept Med, Div Cardiovasc, Philadelphia, PA USA
关键词
D O I
10.1016/j.amjcard.2004.08.013
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The calcified aortic valve lesion develops in the setting of endothelial injury and inflammation and displays hallmarks of atherosclerosis, including lipid accumulation, MMP activation, and interaction with the renin-angiotensin system. In addition to ectopic calcification, bone formation may occur in severely diseased valves. Our understanding of the molecular mechanisms that participate in an aortic valve lesion has lagged behind atherosclerotic disease of arteries. Further understanding of atherosclerotic disease will assuredly yield new insights into valvular heart disease. Current evidence indicates that modification of atherosclerotic risk factors will slow progression of aortic valve calcification, and valve risk factors should be addressed in all patients who have aortic valve calcification. Prospective trials are needed to evaluate therapeutic approaches to prevent progression of aortic valve disease.
引用
收藏
页码:1396 / 1402
页数:7
相关论文
共 94 条
[1]   Aortic valve sclerosis and aortic atherosclerosis: Different manifestations of the same disease? Insights from a population-based study [J].
Agmon, Y ;
Khandheria, BK ;
Meissner, I ;
Sicks, JD ;
O'Fallon, WM ;
Wiebers, DO ;
Whisnant, JP ;
Seward, JB ;
Tajik, AJ .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 38 (03) :827-834
[2]   Making sense of latent TGFβ activation [J].
Annes, JP ;
Munger, JS ;
Rifkin, DB .
JOURNAL OF CELL SCIENCE, 2003, 116 (02) :217-224
[3]   CORRELATION OF SERUM-LIPIDS, CALCIUM, AND PHOSPHORUS, DIABETES-MELLITUS AND HISTORY OF SYSTEMIC HYPERTENSION WITH PRESENCE OR ABSENCE OF CALCIFIED OR THICKENED AORTIC CUSPS OR ROOT IN ELDERLY PATIENTS [J].
ARONOW, WS ;
SCHWARTZ, KS ;
KOENIGSBERG, M .
AMERICAN JOURNAL OF CARDIOLOGY, 1987, 59 (09) :998-999
[4]   Association of coronary risk factors and use of statins with progression of mild valvular aortic stenosis in older persons [J].
Aronow, WS ;
Ahn, C ;
Kronzon, I ;
Goldman, ME .
AMERICAN JOURNAL OF CARDIOLOGY, 2001, 88 (06) :693-695
[5]   Association of cholesterol levels, hydroxymethylglutaryl coenzyme-A reductase inhibitor treatment, and progression of aortic stenosis in the community [J].
Bellamy, MF ;
Pellikka, PA ;
Klarich, KW ;
Tajik, AJ ;
Enriquez-Sarano, M .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 40 (10) :1723-1730
[6]   HMG-CoA reductase inhibitors reduce MMP-9 secretion by macrophages [J].
Bellosta, S ;
Via, D ;
Canavesi, M ;
Pfister, P ;
Fumagalli, R ;
Paoletti, R ;
Bernini, F .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1998, 18 (11) :1671-1678
[7]   Regulation and regulatory activities of transforming growth factor β [J].
Bonewald, LF .
CRITICAL REVIEWS IN EUKARYOTIC GENE EXPRESSION, 1999, 9 (01) :33-44
[8]   Tissue inhibitors of metalloproteinases: evolution, structure and function [J].
Brew, K ;
Dinakarpandian, D ;
Nagase, H .
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEIN STRUCTURE AND MOLECULAR ENZYMOLOGY, 2000, 1477 (1-2) :267-283
[9]   Differential expression of 92-kDa gelatinase in primary atherosclerotic versus restenotic coronary lesions [J].
Brown, DL ;
Hibbs, MS ;
Kearney, M ;
Isner, JM .
AMERICAN JOURNAL OF CARDIOLOGY, 1997, 79 (07) :878-882
[10]   osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification [J].
Bucay, N ;
Sarosi, I ;
Dunstan, CR ;
Morony, S ;
Tarpley, J ;
Capparelli, C ;
Scully, S ;
Tan, HL ;
Xu, WL ;
Lacey, DL ;
Boyle, WJ ;
Simonet, WS .
GENES & DEVELOPMENT, 1998, 12 (09) :1260-1268